Showing results (1181-1190 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|December 28, 2016
Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis BC Q Pan, W Yi, M Liu, et al.Journal of Viral Hepatitis|March 28, 2017
Entecavir maleate versus entecavir in Chinese chronic hepatitis B predominantly genotype B or C: Results at week 144J-H Xu, S Wang, Z-N Xu, et al.Journal of Viral Hepatitis|April 3, 2014
Absence of nonprimate hepacivirus-related genomes in blood donors seroreactive for hepatitis C virus displaying indeterminate blot patternsJ E Levi, S P N Cabral, A Nishiya, et al.Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.Journal of Viral Hepatitis|April 11, 2014
Meta-analysis of observational studies: hepatitis C and survival after renal transplantF Fabrizi, P Martin, V Dixit, et al.Journal of Viral Hepatitis|April 11, 2014
Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatmentC R Werner, C Franz, D P Egetemeyr, et al.Journal of Viral Hepatitis|April 11, 2014
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirinN Harada, N Hiramatsu, T Oze, et al.Journal of Viral Hepatitis|April 23, 2014
HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapyX Zhang, J Jia, J Dong, et al.Pageof 362